venBio Partners LLC
Follow13F filer, CIK 1776382, SAN FRANCISCO, CA
venBio Partners LLC reported $495,928,000 across 9 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.
Accepted , ingested 13F-HR 0000905148-26-004927
- Period
- 2026-09-30
- Reported value
- $496M
- Holdings
- 9
- Top 10 weight
- 100%
- New
- 3
- Sold out
- 1
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ATTOnew | +4,181,366 | $71.7M |
| YARWnew | +554,769 | $12.5M |
| LSTAnew | +156,460 | $225K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| HRMYexited | -472,194 | -$17.2M |
| PHVSreduced | -184,453 | -$5.85M |
| ALMSreduced | -337,000 | -$2.49M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0000905148-26-004927, largest first. % of portfolio is the value over $495,928,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| PBLSPARABILIS MEDICINES INC | 5,266,697 | $170M | 34.29% | 0 | Timeline | ||
| PHVSPHARVARIS N V | 4,458,977 | $141M | 28.52% | -184,453 | Timeline | ||
| ATTOATTOVIA THERAPEUTICS INC | 4,181,366 | $71.7M | 14.45% | new | Timeline | ||
| ACHVACHIEVE LIFE SCIENCE INC | 5,914,720 | $47.9M | 9.65% | 0 | Timeline | ||
| ALMSALUMIS INC | 4,191,408 | $31M | 6.25% | -337,000 | Timeline | ||
| ALXOALX ONCOLOGY HLDGS INC | 12,884,638 | $17.9M | 3.61% | 0 | Timeline | ||
| YARWYARROW BIOSCIENCE INC | 554,769 | $12.5M | 2.52% | new | Timeline | ||
| LYELLYELL IMMUNOPHARMA INC | 337,697 | $3.31M | 0.67% | 0 | Timeline | ||
| LSTALISATA THERAPEUTICS INC | 156,460 | $225K | 0.05% | new | Timeline |
Sold out in Q3 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| HRMYHARMONY BIOSCIENCES HLDGS IN | 472,194 | $17.2M | shares |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000905148-26-004927 | base | 2026-11-16 |